Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30144% above fair value
$55.93+0.53 (+0.96%)
Close on Nov 13, 2026Market cap $3.34BP/E –Yield –
Axogen statistics
91 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 23, 2027 (estimated, before the open)
- Last ex-dividend date
- Jan 27, 2010
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 6.84
- 4.81
- P/OCF Ratio
- 117.80
- 21.97
Enterprise valuationIndustry
- EV / Sales
- 11.21
- 2.60
- EV / FCF
- 135.79
- 27.51
Share statisticsIndustry
- Shares Change (YoY)
- 13.0%
- 3.32%
- Shares Change (QoQ)
- 11.3%
- 0.20%
- Float
- 55M
- 37M
- Shares Held by Insiders
- 7.65%
- 10.5%
- Shares Held by Institutions
- 90.4%
- 60.5%
Short sellingIndustry
- Short Interest
- 7M
- –
- Short Interest Change
- 36.5%
- -2.57%
- Short % of Float
- 12.7%
- 5.11%
- Short % of Shares Outstanding
- 11.7%
- 3.98%
- Days to Cover
- 3.28
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $59.72
- –
- 52-Week Low
- $23.00
- –
- 20-Day Moving Average
- $46.37
- –
- 50-Day Moving Average
- $43.27
- –
- 200-Day Moving Average
- $40.53
- –
- Average True Range (14)
- $2.96
- –
- Price Change (1 Week)
- 11.8%
- 0.99%
- Price Change (1 Month)
- 57.0%
- -3.52%
- Price Change (3 Months)
- 13.8%
- -7.86%
- Price Change (6 Months)
- 36.4%
- -1.12%
- Price Change (YTD)
- 70.9%
- -2.92%
- Price Change (1 Year)
- 132.2%
- -1.37%
- Price Change (3 Years)
- 895.2%
- 3.24%
- Price Change (5 Years)
- 359.6%
- -50.4%
- Price Change (10 Years)
- 554.2%
- 58.9%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.97
- 0.76
- Relative Strength Index (14)
- 69.9
- 46.7
- Volatility (1 Year)
- 61.1%
- 64.2%
- Beta (5 Years)
- 1.16
- 1.04
MarginsIndustry
- EBITDA Margin
- -2.77%
- -2.52%
- FCF Margin
- 8.26%
- 0.65%
Returns on capitalIndustry
- Return on Equity (ROE)
- -10.3%
- -17.3%
- Return on Assets (ROA)
- -8.33%
- -12.3%
- Return on Invested Capital (ROIC)
- -7.87%
- -2.83%
- Return on Capital Employed (ROCE)
- -2.69%
- -8.13%
Financial positionIndustry
- Current Ratio
- 12.02
- 2.49
- Quick Ratio
- 10.48
- 1.53
- Debt / Equity
- 0.00
- 0.42
- Debt / FCF
- 0.00
- 3.62
- Interest Coverage
- -5.72
- -1.63
GrowthIndustry
- Revenue Growth (YoY)
- 24.3%
- 9.42%
- FCF Growth (YoY)
- 559.7%
- 7.64%
- Revenue Growth (3Y CAGR)
- 17.6%
- 7.08%
- Revenue Growth (5Y CAGR)
- 14.9%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 0.70
- 0.59
- Inventory Turnover
- 1.54
- 2.20
- Revenue Per Employee
- $429.14K
- $331.99K
- Profits Per Employee
- -$51.32K
- -$46.47K
- Employee Count
- 622
- 193
- WACC
- 10.9%
- 9.91%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $348.07M
- $3.95M
- Net Cash Per Share
- $5.83
- $0.26
- Equity (Book Value)
- $496.10M
- $63.80M
- Book Value Per Share
- $8.31
- $3.26
- Tangible Book Value
- $488.19M
- $11.61M
- Working Capital
- $401.64M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$6.32M
- -$3.94M
- FCF Per Share
- $0.37
- -$0.00
Dividends and yieldsIndustry
- Earnings Yield
- -0.96%
- -4.76%
- FCF Yield
- 0.66%
- 0.28%
Taxes and interestIndustry
- Interest Expense
- $2.41M
- $5.40M
- Income Tax
- $0
- $1.55M
Scores and fair valueIndustry
- Altman Z-Score
- 37.41
- 2.47
- Piotroski F-Score
- 5
- 5
- Beneish M-Score
- -2.72
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AXGN | S&P 500 | Difference | AXGN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +54.6% | -3.0% | +57.7 pts | ||
| 3 months | +16.4% | -2.8% | +19.2 pts | ||
| Year to date | +70.9% | +11.5% | +59.4 pts | ||
| 1 year | +132.7% | +13.5% | +119.2 pts | ||
| 3 years | +986.0% | +77.7% | +908.3 pts | +121.5% | +21.1% |
| 5 years | +359.6% | +72.6% | +287.0 pts | +35.7% | +11.5% |
| 10 years | +554.2% | +308.2% | +246.0 pts | +20.7% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
7M AXGN shares were sold short on Oct 30, 2026, up 36.5% from the previous report, or 12.67% of the shares available to trade. At recent volumes it would take 3.3 days to buy them back. Over the last 20 sessions, 36.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 6,991,930 | +36.5% | 2,130,161 | 3.3 |
| Oct 15, 2026 | 5,123,544 | +9.1% | 1,694,942 | 3.0 |
| Sep 30, 2026 | 4,697,283 | +15.8% | 1,127,117 | 4.2 |
| Sep 15, 2026 | 4,055,417 | +6.5% | 1,418,348 | 2.9 |
| Aug 31, 2026 | 3,809,350 | +13.2% | 903,167 | 4.2 |
| Aug 14, 2026 | 3,365,313 | -17.3% | 826,554 | 4.1 |
| Jul 31, 2026 | 4,071,593 | -25.2% | 1,217,149 | 3.4 |
| Jul 15, 2026 | 5,443,801 | +17.4% | 1,495,870 | 3.6 |
| Jun 30, 2026 | 4,634,995 | +26.5% | 1,628,697 | 2.9 |
| Jun 15, 2026 | 3,663,617 | +8.7% | 1,218,478 | 3.0 |
| May 29, 2026 | 3,369,844 | +5.2% | 811,549 | 4.2 |
| May 15, 2026 | 3,202,431 | -5.9% | 786,698 | 4.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?